Bristol Haematology and Oncology Centre

Name :

Bristol Haematology and Oncology Centre

Address  :

Horfield Road

Town  :

Bristol

State  :

Bristol

Country  :

UK

Post Code:

BS2 8ED

Phone  :

0117 342 3369

Fax  :

0117 342 2498

Web URL  :

Specialization
  • Chemotherapy
  • Gynaecology
  • Hematologist
  • Oncologist
  • Radiation therapy
Facilities

Description

BHOC provides specialist nonsurgical treatments for people with cancer and for people who do not have cancer but require specialist radiotherapy or haematology services The three main specialities are oncology haematology and palliative care

We are the only Comprehensive Care Centre for Haemophilia in the South West As well as being the cancer treatment centre for Bristol South Gloucestershire and North Somerset we provide specialist services to people from across the South West We are part of the Avon Somerset and Wiltshire Cancer network

There are two wards in BHOC Ward 61 oncology Ward 62 haematology and two day units chemotherapy and haematology There is a combined outpatients department The radiotherapy treatment floor on LG2 lower ground 2 has five linacs linear accelerators and a brachytherapy theatre The building houses an isotopes unit with 5 singlebedded rooms on an isolation corridor on Ward 61

Chemotherapy in the community
BHOC provides services in the community at our satellite clinic at Whitchurch Health Centre Wed Fri and giving chemotherapy in patients homes in partnership with NHS Bristol and Healthcare at Home

Clinical trials unit
The trials team ensure that patients have the opportunity to be involved in relevant studies and provide information support treatment and followup as part of the Avon Somerset and Wiltshire Cancer Research Network ASWCRN
Karmanos Cancer Center receives HealthGrades 2012 Outstanding Patient Experience Award

HealthGrades analyzed patient satisfaction data for 3837 hospitals in the country using Hospital Consumer Assessment of Healthcare Providers and Systems HCAHPS hospital survey data obtained from the Centers for Medicare and Medicaid Services CMS The information was compiled from surveys given to a random sample of patients who were discharged from ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More